Nitric oxide inhalation modulates endothelin-1 plasma concentration gradients following left ventricular assist device implantation

Journal of Cardiovascular Pharmacology

Volumn 44, Issue SUPPL. 1, 2004, Pages

  Wagner, Frank ^a   Buz, Semih ^a   Neumeyer, Hans H ^b   Hetzer, Roland ^a   Hocher, Berthold ^b  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Endothelin 1 (ET 1); Left ventricular assist device (LVAD); Nitric oxide (NO)

Indexed keywords

ENDOTHELIN 1; NITRIC OXIDE;

ADULT; ASSISTED CIRCULATION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY BLOOD VESSEL; FEMALE; HEART ASSIST DEVICE; HUMAN; IMPLANTATION; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY ARTERY ANEURYSM; PULMONARY HYPERTENSION; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, INHALATION; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIAC OUTPUT, LOW; CARDIOPULMONARY BYPASS; CENTRAL VENOUS PRESSURE; DOWN-REGULATION; ENDOTHELIN-1; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; HYPERTENSION, PULMONARY; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; NITRIC OXIDE; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 11144276627     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000166206.74178.99     Document Type: Conference Paper

References (7)

1. Wagner F, Dandel M, Günther G, et al. Nitric oxide inhalation in the treatment of right ventricular dysfunction following left ventricular assist device implantation. Circulation. 1997;96:II-291-II-296.
2. Wagner FD, Buz S, Knosalla C, Hetzer R, Hocher B. Modulation of circulating endothelin-1 and big endothelin by nitric oxide inhalation following left ventricular assist device implantation. Circulation. 2003; 108:II-278-II-284.
3. Slowinski T, Neumayer HH, Stolze T, et al. Endothelin system in normal and hypertensive pregnancy. Clin Sci (Lond). 2002;103:S446-S449.
4. Zellers TM, McCormick J, Wu Y. Interaction among ET-1, endothelium-derived nitric oxide, and prostacyclin in pulmonary arteries and veins. Am J Physiol. 1994;267:H139-H147.
5. Moraes DL, Colucci WS, Givertz MM. Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. Circulation. 2000;102:1718-1723.
6. Kirshbom PM, Jacobs MT, Tsui SS, et al. Effects of cardiopulmonary bypass and circulatory arrest on endothelium-dependent vasodilation in the lung. J Thorac Cardiovasc Surg. 1996;111:1248-1256.
7. Stangl K, Dschietzig T, Richter C, et al. Pulmonary release and coronary and peripheral consumption of big endothelin and endothelin-1 in severe heart failure: acute effects of vasodilator therapy. Circulation. 2000;102:1132-1138.